Lupin Limited gets FDA warning letter for Lupin Somerset site

Lupin Limited gets FDA warning letter for Lupin Somerset site

Indian pharma company Lupin Limited said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its manufacturing facility in Somerset, New Jersey. The warning letter follows inspections of the Lupin Somerset site by the FDA from 10 September 2020 to 5 November 2020. Lupin Limited said that […]